IMO-2125, A TLR9 AGONIST, INDUCES IMMUNE RESPONSES WHICH CORRELATE WITH REDUCTIONS IN VIRAL LOAD IN NULL RESPONDER HCV PATIENTS

IMO-2125, A TLR9 AGONIST, INDUCES IMMUNE RESPONSES WHICH CORRELATE WITH REDUCTIONS IN VIRAL LOAD IN NULL RESPONDER HCV PATIENTS: 33 Maribel Rodriguez-Torres;Reem Ghalib;Stuart Gordon;Eric Lawitz;Keyur Patel;Ronald Pruitt;Aasim Sheikh;Robert Arbeit;Alice Bexon;Ekambar Kandimalla;Melissa Precopio;Tim Sullivan;Andrew Muir;John McHutchison; Hepatology